7-chlorokynurenic acid has been researched along with Learning Disabilities in 2 studies
7-chlorokynurenic acid: selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex; structure given in first source
7-chlorokynurenic acid : A quinolinemonocarboxylic acid that is quinaldic acid which is substituted by a hydroxy group at position 4 and by a chlorine at position 7. It is a potent NMDA glutamate receptor antagonist which antagonizes the strychnine-insensitive glycine site of the NMDA receptor. It also prevents neurodegeneration produced by quinolinic acid.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wood, ER | 1 |
Bussey, TJ | 1 |
Phillips, AG | 1 |
Carli, M | 1 |
Bonalumi, P | 1 |
Samanin, R | 1 |
2 other studies available for 7-chlorokynurenic acid and Learning Disabilities
Article | Year |
---|---|
A glycine antagonist 7-chlorokynurenic acid attenuates ischemia-induced learning deficits.
Topics: Analysis of Variance; Animals; Cerebral Ventricles; Discrimination, Psychological; Glycine; Hippocam | 1993 |
WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid.
Topics: Animals; Excitatory Amino Acid Antagonists; Hippocampus; Injections; Kynurenic Acid; Learning Disabi | 1997 |